Study Stopped
Re-definition of MIRA technology goals.
Imaging Modality Effects on the Multi-dimensional InfraRed Analysis (MIRA) Technology
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of everyday practice modalities (mammography, US) on the MIRA technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2009
CompletedFirst Posted
Study publicly available on registry
December 10, 2009
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedApril 27, 2017
May 1, 2015
1 year
December 9, 2009
April 25, 2017
Conditions
Eligibility Criteria
Subjects arriving for a mammography or breast ultrasound
You may qualify if:
- Gender: female
- Age: 50 years and older
- Subjects summoned for a routine screening mammography, ultrasound, diagnostic mammography or breast biopsy.
- Subject who have signed an informed consent form.
You may not qualify if:
- Subjects who have had a mammography, ultrasound, and/or MRI examination performed on the day of the study, PRIOR to their FIRST imaging session with the RealImager.
- Subjects who have undergone any type of breast surgery throughout the 6 weeks preceding the study.
- Subjects who have had a breast biopsy performed throughout the 6 weeks preceding the study.
- Subjects who have undergone a mastectomy.
- Subjects who have undergone a lumpectomy.
- Subjects who have a large scar (causing breast deformation).
- Subjects who have previously undergone or are currently undergoing breast radiation therapy.
- Subjects who have previously undergone or are currently undergoing chemotherapy.
- Subjects with prior breast reduction surgery or breast augmentation surgery.
- Subjects who are pregnant.
- Subjects who are breast-feeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Center
Jerusalem, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2009
First Posted
December 10, 2009
Study Start
May 1, 2015
Primary Completion
May 1, 2016
Study Completion
December 1, 2016
Last Updated
April 27, 2017
Record last verified: 2015-05